Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:HUGE - Post by User

Comment by GrahamBon May 07, 2023 12:36pm
76 Views
Post# 35435302

RE:RE:RE:RE:RE:RE:Blackjack

RE:RE:RE:RE:RE:RE:BlackjackDidnt see the article, but FSD at one point gave millions to Solar to develop cannabis from algae.
Another failure in planning -never understood thgat science project.
Solarvest is in rough shape now:

"As of January 31, 2023, the Company had cash and cash equivalents of $90,421, a working capital deficit of $1,752,397 and an accumulated deficit of $17,518,048. The Company also had a net loss of $977,398 and negative cash flows from operations of $716,328 for the six-months ended January 31, 2023. Due to limited cash flows from operations, the Company and its subsidiaries have missed making vendor and interest payments. Refer to “Liquidity and Capital Resources” for additional information on the Company’s cash position. As of the date of this MD&A, management does not believe that the Company’s cash balance is sufficient to meet its general working capital requirements and contractual obligations for the next 12 months.
Debt refinancing of the Company, the raising of additional capital,"source sedar.com
<< Previous
Bullboard Posts
Next >>